Type 2 diabetes mellitus (diabetes) Nutritional, Metabolic, Endocrine
Conditions
Interventions
For each medical record, HbA1c (a measure of average blood glucose) will be collected after 3 to 6 months of use of the FreeStyle Libre and compared with HbA1c from before starting FreeStyle Libre.
Sponsors
Abbott Diabetes Care
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Age 18 years or over at the time of starting a FreeStyle Libre system 2. Has type 2 diabetes using pre-mixed insulin only or pre-mixed insulin in combination with oral and/or injectable (non-insulin) medications for at least 1 year prior to starting a FreeStyle Libre system 3. Has used a FreeStyle Libre system regularly for at least 3 months 4. HbA1c recorded in medical notes between 8.0% and 12.0% (64 to 108 mmol/mol) in the 3 months prior to starting a FreeStyle Libre system 5. HbA1c recorded in medical notes 3 to 6 months after starting a FreeStyle Libre system
Exclusion criteria
Exclusion criteria: 1. Has used bolus or basal insulin during the data collection period 2. Female participant who was pregnant during the data collection period 3. Received dialysis treatment during the data collection period 4. Participated in another medical device or drug study that, in the Investigator’s opinion, could have affected glucose measurements or management during the data collection period
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in HbA1c from baseline to 3 to 6 months after initiation of FreeStyle Libre measured using patient records | — |
Secondary
| Measure | Time frame |
|---|---|
| There are no secondary outcome measures | — |
Countries
England, United Kingdom, Wales
Contacts
Public ContactPamela Reid
Outcome results
None listed